UBS Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-480
| Closed | -$1.79K | – | 9363 |
|
|
2024
Q3 | $1.79K | Sell |
480
-2
| -0.4% | -$7 | ﹤0.01% | 7337 |
|
|
2024
Q2 | $2.7K | Sell |
482
-11,707
| -96% | -$65.6K | ﹤0.01% | 7149 |
|
|
2024
Q1 | $63.9K | Buy |
12,189
+3,818
| +46% | +$20K | ﹤0.01% | 5245 |
|
|
2023
Q4 | $43.8K | Sell |
8,371
-9,501
| -53% | -$49.7K | ﹤0.01% | 5416 |
|
|
2023
Q3 | $282K | Sell |
17,872
-19,410
| -52% | -$306K | ﹤0.01% | 4023 |
|
|
2023
Q2 | $725K | Buy |
37,282
+26,563
| +248% | +$516K | ﹤0.01% | 3544 |
|
|
2023
Q1 | $304K | Sell |
10,719
-34,964
| -77% | -$992K | ﹤0.01% | 4057 |
|
|
2022
Q4 | $1.34M | Buy |
45,683
+35,780
| +361% | +$1.05M | ﹤0.01% | 2900 |
|
|
2022
Q3 | $261K | Buy |
9,903
+1,388
| +16% | +$36.6K | ﹤0.01% | 3865 |
|
|
2022
Q2 | $378K | Sell |
8,515
-18,549
| -69% | -$823K | ﹤0.01% | 3539 |
|
|
2022
Q1 | $1.34M | Sell |
27,064
-6,648
| -20% | -$329K | ﹤0.01% | 2986 |
|
|
2021
Q4 | $1.72M | Buy |
33,712
+10,508
| +45% | +$535K | ﹤0.01% | 2999 |
|
|
2021
Q3 | $1.3M | Buy |
23,204
+15,103
| +186% | +$843K | ﹤0.01% | 3061 |
|
|
2021
Q2 | $347K | Sell |
8,101
-13,178
| -62% | -$564K | ﹤0.01% | 3984 |
|
|
2021
Q1 | $888K | Buy |
21,279
+21,229
| +42,458% | +$886K | ﹤0.01% | 3474 |
|
|
2020
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 7102 |
|
|
2020
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 6821 |
|
|
2020
Q2 | $2K | Sell |
50
-3,429
| -99% | -$137K | ﹤0.01% | 6811 |
|
|
2020
Q1 | $160K | Sell |
3,479
-2,199
| -39% | -$101K | ﹤0.01% | 4056 |
|
|
2019
Q4 | $342K | Sell |
5,678
-20,760
| -79% | -$1.25M | ﹤0.01% | 4205 |
|
|
2019
Q3 | $1.5M | Sell |
26,438
-15,477
| -37% | -$875K | ﹤0.01% | 2878 |
|
|
2019
Q2 | $2.33M | Buy |
41,915
+38,608
| +1,167% | +$2.15M | ﹤0.01% | 2393 |
|
|
2019
Q1 | $167K | Sell |
3,307
-77,885
| -96% | -$3.93M | ﹤0.01% | 3970 |
|
|
2018
Q4 | $3.27M | Buy |
81,192
+69,367
| +587% | +$2.79M | ﹤0.01% | 2032 |
|
|
2018
Q3 | $820K | Buy |
11,825
+11,346
| +2,369% | +$787K | ﹤0.01% | 3308 |
|
|
2018
Q2 | $36K | Sell |
479
-47,501
| -99% | -$3.57M | ﹤0.01% | 5353 |
|
|
2018
Q1 | $2.53M | Buy |
47,980
+37,597
| +362% | +$1.98M | ﹤0.01% | 2380 |
|
|
2017
Q4 | $554K | Sell |
10,383
-17,186
| -62% | -$917K | ﹤0.01% | 3394 |
|
|
2017
Q3 | $1.64M | Buy |
27,569
+13,914
| +102% | +$830K | ﹤0.01% | 2637 |
|
|
2017
Q2 | $1.08M | Buy |
13,655
+12,318
| +921% | +$972K | ﹤0.01% | 2862 |
|
|
2017
Q1 | $111K | Sell |
1,337
-18,347
| -93% | -$1.52M | ﹤0.01% | 4151 |
|
|
2016
Q4 | $1.56M | Buy |
19,684
+15,469
| +367% | +$1.23M | ﹤0.01% | 2469 |
|
|
2016
Q3 | $295K | Sell |
4,215
-13,607
| -76% | -$952K | ﹤0.01% | 3476 |
|
|
2016
Q2 | $692K | Buy |
17,822
+8,726
| +96% | +$339K | ﹤0.01% | 2941 |
|
|
2016
Q1 | $368K | Sell |
9,096
-22,009
| -71% | -$890K | ﹤0.01% | 3341 |
|
|
2015
Q4 | $2.76M | Buy |
31,105
+24,177
| +349% | +$2.14M | ﹤0.01% | 1953 |
|
|
2015
Q3 | $513K | Buy |
6,928
+1,255
| +22% | +$92.9K | ﹤0.01% | 3086 |
|
|
2015
Q2 | $458K | Buy |
+5,673
| New | +$458K | ﹤0.01% | 3331 |
|